Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Isconova AB

Division of Novavax Inc.
www.isconova.se

Latest From Isconova AB

Genocea Aims To Take The T-Cell Century By The Horns

Although cancer grabs the spotlight for harnessing the immune system against tumors, other therapeutic areas and modalities are being developed in the shadows. Genocea Biosciences thinks it has a surefire way to identify novel antigens for T-cell vaccines. It hopes to shake up large infectious disease markets, and more.

BioPharmaceutical Business Strategies

Novavax Eyes Asia Expansion As Vaccines Portfolio Progresses

The U.S. vaccines company Novavax is making inroads into Asia and developing markets with its influenza and RSV vaccines.

BioPharmaceutical United States

Novavax Eyes Asia Expansion As Vaccines Portfolio Progresses

The U.S. vaccines company Novavax is making inroads into Asia and developing markets with its influenza and RSV vaccines.

BioPharmaceutical India

Deals Shaping The Medical Industry, October 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced August through September 2013.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Sweden
  • Parent & Subsidiaries
  • Novavax Inc.
  • Senior Management
  • Erik Bergman, CFO
    Karin Lovgren Bengtsson, CSO
    Thomas Phillipson, Dir., Sales & Mktg.
    Johan Anstrén, Dir., Bus. Dev.
  • Contact Info
  • Isconova AB
    Phone: (46) 18 16 17 00
    Kungsgatan 109
    Uppsala, SE- 753 18
    Sweden
Advertisement
Advertisement
UsernamePublicRestriction

Register